ORTHOTEC EVOLUTION
ActiveORTHOTEC EVOLUTION has been active since 2017 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (€-21k) and a net result of €-1k. Equity is shrinking by ~42.7% per year across the filed fiscal years. Its solvency ranks better than 5% of 214 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.9% (low).
Checked score
Score 2025
Axes · tick = 2024
Profitability28▼-72
Solvency67▲+17
Growth58▲+26
Stability100
Bankruptcy probability, 12 months
0.9%
Low
0%0.5%1.5%4%10%≥ 25%
No credit on open account
Liquidity ample (current ratio 34.41), but equity is negative.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
-118.9%
Return on assets
-6.7%
Age of the figures
8 mo
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 32
Relative position
BE, all sectors
reference
Sector 32
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Negative equity
Equity is negative for financial year 2025: liabilities exceed assets. This is the trigger point of the alarm-bell procedure (Belgian CAC).
NBB · annual accounts 2025Equity per financial year
1819202122232425
2018 to 2025 · latest year -€21k
neutral · A punctual record breaks
This company filed 4 consecutive financial years on time. The year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-08-2026, 30 days late. Weigh it accordingly: a break into the 1-to-90-day band measures 1.41% abnormal legal state, below the 1.66% market average. It is a change in behaviour, not evidence of elevated risk.
NBB · 8 filingsDeviation from the deadline
2025
30 d late
2024
6 d early
2023
7 d early
2022
4 d early
2021
5 d early
2020
23 d late
2019
74 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
12-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€-1k▲ 74.6%
2024 · €-5k
2018: €-3k
2019: €10k
2020: €8k
2021: €-10k
2022: €-13k
2023: €-16k
2024: €-5k
2018 → 2025
Working capital
€17k▼ 55.3%
2023 · €38k
2018: €-4k
2019: €61k
2020: €85k
2022: €91k
2023: €38k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€14k-€1k▼ 91.4%€-15k€-20k▼ 30.5%€-21k▼ 5.9%
Operating result€-10k-€-13k▼ 33.4%€-16k▼ 25.6%€-4k▲ 73.9%€-1k▲ 74.0%
Net result€-10k-€-13k▼ 31.3%€-16k▼ 27.0%€-5k▲ 71.7%€-1k▲ 74.6%
Result per fiscal year
Operating resultNet result
The operating result stays negative: a loss of €1k in 2025 against €4k in 2024; the loss shrinks.
Key figures and ratios
Solvency
-118.9%▼
2024 · -51.6%
Current ratio
34.41
Quick ratio
34.41
Debt / equity
-1.84▲
2024 · -2.94
ROE
5.6%▼
2024 · 23.4%
ROA
-6.7%▲
2024 · -12.1%
Debt
€39k▼
2024 · €58k
Debt ≤ 1 year
€511
Debt > 1 year
€38k▼
2024 · €58k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€38k€18k▼
Current assets29/58€38k€18k▼
Amounts receivable within one year40/41€8k€3k▼
Trade receivables40€5k-
Other amounts receivable41€3k€3k=
Cash at bank and in hand54/58€30k€14k▼
Equity and liabilities
Total equity and liabilities10/49€38k€18k▼
Equity10/15€-20k€-21k▼
Contributions10/11€6k€6k=
Outside capital11€6k€6k=
Other1109/19€6k€6k=
Profit (loss) carried forward14€-26k€-27k▼
Amounts payable17/49€58k€39k▼
Amounts payable after more than one year17€58k€38k▼
Financial debts170/4€58k€38k▼
Amounts payable within one year42/48-€511
Trade debts44-€511
Suppliers440/4-€511
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€5k-
Other operating charges640/8€163€88▼
Non-recurring operating charges66A-€599
Gross operating margin9900€544€-424▼
Operating profit (loss)9901€-4k€-1k▲
Financial income75/76B€34-
Recurring financial income75€34-
Financial charges65/66B€372€61▼
Recurring financial charges65€80€61▼
Non-recurring financial charges66B€292-
Profit (loss) for the period before taxes9903€-5k€-1k▲
Profit (loss) for the period9904€-5k€-1k▲
Profit (loss) for the period to be appropriated9905€-5k€-1k▲
Appropriation of the result
Profit (loss) to be appropriated9906€-26k€-27k▼
Profit (loss) brought forward from the previous period14P€-21k€-26k▼
The notes to these accounts (3 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
30-08
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 30 days late
2025
25-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
24-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Weakest financial yearnet €-16k
Net result drops to €-16k, the lowest in the series; recovery starts the following year.
27-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
26-07
NBB filing
Annual accounts filed
fiscal year 2021 · full schema
2021
23-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 23 days late
2020
31-12
Financial
Liquidity quadruplescurrent ratio 12.54
Current ratio from 3.08 to 12.54; short-term debt falls from €30k to €7k.
13-10
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 74 days late
2019
31-12
Financial
Back to profitnet €10k
Net result €10k after one loss-making year.
31-12
Financial
Liquidity times 31current ratio 3.08
Current ratio from 0.10 to 3.08.
28-08
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 28 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Seraing · 1 establishment unit since 2019
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Chaussée de la Troque 204100 Seraing1 establishment unit
ORTHOTEC EVOLUTION
since 20192.285.087.594
Similar companies · same sector, comparable size
Lyande
BE 0806.839.070
Kalmthout · Eq €1k
LABODENTAL
BE 0835.681.328
Schaarbeek · Eq €1k
DENTAL HIGH-TECH
BE 0734.398.777
Braine-l'Alleud · Eq €1k
3D FUTURE AND SOUND TECHNOLOGY
BE 0427.792.566
Braine-l'Alleud · Eq €1k
PERMIGANAU
BE 0768.852.484
Jemeppe-sur-Sambre · Eq €2k
Of 1,245 companies in sector 32500 we hold annual accounts for 692. 52 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded19-10-2017
Fiscal year end31-12
Activities, NACEBEL
32500Manufacture of medical and dental instruments and supplies
46150Agents in the wholesale of furniture, household goods and hardware
Sources
Crossroads Bank for EnterprisesNational Bank · 8 filings
Data from official sources, last processed on 11-09-2026. Scores and ratios are computed by Checked and are not a credit decision.